YMI

YM Biosciences (YMI)

YM Biosciences Ordinary Shares (Canada)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:YMI

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2011/07/07	06 : 27	Edgar (US Regulatory)	Appointment of Agent for Service of Process and Undertaking (F-X)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/07/07	06 : 18	Edgar (US Regulatory)	Registration statement for securities of certain Canadian issuers under the Securities Act of 1933 (F-10)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/06/04	04 : 04	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/06/04	04 : 00	PR Newswire (US)	YM BioSciences Reports Interim Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASCO	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/06/04	00 : 51	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-K/A)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/06/01	00 : 41	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/31	22 : 27	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/31	20 : 00	PR Newswire (US)	YM BioSciences Announces Orphan Drug Designation for JAK1/JAK2 Inhibitor CYT387 in Europe	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/31	06 : 00	PR Newswire (US)	YM BioSciences Provides Update on the Development Program for Nimotuzumab	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/20	01 : 34	Dow Jones News	Cancer Data Deluge Ripples Through Biotech Stocks	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/19	19 : 04	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/19	07 : 05	PR Newswire (US)	YM BioSciences Reports Updated 12-Week Phase I/II Results for its JAK1/JAK2 Inhibitor CYT387	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/13	02 : 04	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/12	19 : 06	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/05/12	06 : 57	PR Newswire (US)	YM BioSciences Reports Fiscal Third Quarter 2011 Operational and Financial Results	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/04/21	02 : 28	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/04/19	04 : 40	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/04/19	03 : 49	PR Newswire (US)	YM BioSciences Reports Positive Updated Anemia Response Data for its JAK1/JAK2 Inhibitor CYT387 Disclosed at First Annual Floren	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/03/31	21 : 16	Marketwired	Speculative Biotech Firms Grapple With Difficult Approval Process	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/03/19	03 : 34	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-K/A)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/03/19	03 : 33	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/03/17	19 : 06	Edgar (US Regulatory)	Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/02/15	09 : 13	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/02/15	08 : 41	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/02/12	05 : 55	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/02/11	20 : 10	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/02/11	05 : 17	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/02/10	22 : 00	PR Newswire (US)	YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/01/21	20 : 03	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)
2011/01/21	07 : 00	PR Newswire (US)	YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium	AMEX:YMI	YM Biosciences Ordinary Shares (Canada)